Regulatory Update

Posted 01 July 2011 | By

On 27 May 2011, the Council of European Union (EU) adopted the Falsified Medicines Directive, which is meant to prevent falsified medicines from entering into the legal supply chain. The new directive includes substantive changes to Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) for active pharmaceutical ingredients (APIs) and excipients.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe